REGN Competitors - Regeneron Pharmaceuticals, Inc. logo

REGN Competitors

Regeneron Pharmaceuticals, Inc.

$778.36
+$25.24(+3.35%)
59
Overall
80
Value
40
Tech
57
Quality
How is this score calculated?
Market Cap
$80.14B
Volume
878.09K
52W Range
$541.00 - $859.34
Target Price
$861.62

REGN competitors: AMGN, ALNY, BIIB, SNY, NVS. Regeneron Pharmaceuticals, Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.

REGN Competitors Compared

CompanyPriceMarket capEPS est. (current yr)Dividend yieldMarketXLS Rank
AMGN Amgen Inc.$426.11$230.37B$22.942.33%65
ALNY Alnylam Pharmaceuticals, Inc.$224.47$30.04B$6.68-34
BIIB Biogen Inc.$232.83$34.40B$12.41-72
SNY Sanofi$39.77$95.41B$5.006.08%60
NVS Novartis AG$146.88$280.27B$8.893.25%53
ABCD
1SymbolPriceChangeVol
2REGN$778.36+3.4%878.09K
3
4
5
6

Get Regeneron Pharmaceuticals, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.